TITLE

HIV-1, NFAT, and Cyclosporin: Immunosuppression for the Immunosuppressed?

AUTHOR(S)
Cron, Randy Q.
PUB. DATE
December 2001
SOURCE
DNA & Cell Biology;Dec2001, Vol. 20 Issue 12, p761
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The human immunodeficiency virus-1 (HIV-1), the cause of AIDS, remains a significant cause of morbidity and mortality throughout the planet. Although reverse transcriptase and protease inhibitors have substantially slowed the virus, viral resistance complicates therapy. Because HIV-1 relies on its host's transcriptional machinery for its own replication, strategies for targeting activation-dependent transcription factors in CD4 T cells are being considered for adjunctive therapy in HIV-1-infected individuals. The nuclear factor of activated T cells (NFAT) family of transcription factors is one such target. On T-cell stimulation, NFAT proteins translocate to the nucleus, where they activate a large number of early response genes, including cytokines such as interleukin-2. Activation and nuclear translocation of NFAT proteins are abrogated by the powerful immunosuppressants cyclosporin A (CsA) and FK506. Over the last several years, various investigators have demonstrated that NFAT proteins bind to the HIV-1 LTR promoter and increase viral transcription. In this report, further evidence supporting a role for NFAT proteins in augmenting HIV-1 transcription is presented. In addition, other mechanisms of HIV-1 inhibition by CsA are reviewed, and the rationale for the use of CsA to treat AIDS is discussed.
ACCESSION #
6366351

 

Related Articles

  • HIV nuclear import: What's the flap? Stevenson, Mario // Nature Medicine;Jun2000, Vol. 6 Issue 6, p626 

    Focuses on a triple stranded HIV cDNA intermediate of reverse transcription as a component of HIV nuclear import. Flow of genetic information from a retrovirus; Formation of reverse transcription complex; Models of flap-dependent HIV nuclear import.

  • What is new in the nucleolus?: Workshop on the Nucleolus: New Perspectives. Matthews, David A.; Olson, Mark O. J. // EMBO Reports;Sep2006, Vol. 7 Issue 9, p870 

    The article reports on the "EMBO Workshop on the Nucleolus: New Perspectives," held at York, United Kingdom, from March 27-29, 2006. Information on the main focus of the workshop that revealed the involvement of nucleolus in internal functions of cells is presented. An overview of the structure,...

  • Viral infection: Interfering with HIV infection. Hofer, Ursula // Nature Reviews Microbiology;Nov2013, Vol. 11 Issue 11, p742 

    The article reports on studies which identified an HIV restriction factor, the antiviral cytokine interferon (IFNa)-inducible myxovirus resistance 2 (MX2) protein. It refers to the identification of 14 IFN-induced genes that were upregulated in responsive HIV-resistant cells through...

  • Decreased HIV Type 1 Transcription in CCR5-Δ32 Heterozygotes During Suppressive Antiretroviral Therapy. Wang, Charlene; Abdel-Mohsen, Mohamed; Strain, Matthew C.; Lada, Steven M.; Yukl, Steven; Cockerham, Leslie R.; Pilcher, Christopher D.; Hecht, Frederick M.; Sinclair, Elizabeth; Liegler, Teri; Richman, Douglas D.; Deeks, Steven G.; Pillai, Satish K. // Journal of Infectious Diseases;Dec2014, Vol. 210 Issue 11, p1838 

    Individuals who are heterozygous for the CCR5-Δ32 mutation provide a natural model to examine the effects of reduced CCR5 expression on human immunodeficiency virus (HIV) persistence. We evaluated the HIV reservoir in 18 CCR5-Δ32 heterozygotes and 54 CCR5 wild-type individuals during...

  • Targeting a deadly scrap of genetic code. Cowley, Geoffrey; Hager, Mary // Bulletin with Newsweek;12/10/96, Vol. 116 Issue 6050, p68 

    Looks at the genetic aspects of the human immunodeficiency virus (HIV). How HIV invades the body's immune system; Potential treatments; Side-effects of present HIV treatments; A diagram visually depicting how HIV infects the immune system.

  • Rare find.  // Advocate;12/12/95, Issue 696, p11 

    Reports on the discovery of a rare strain of HIV that does not cause AIDS by a team of Australian researchers. Implications to research concerning vaccines and drugs for AIDS.

  • Specific incorporation of cyclophilin A into HIV-1 virions. Franke, Ettaly Kara; Yuan, Hannah En Hui // Nature;11/24/1994, Vol. 372 Issue 6504, p359 

    Demonstrates the incorporation of cyclophilin A into HIV-1 virions but not in other primate immunodeficiency viruses. Requirements of cyclophilin A binding; Effect of Gag polyprotein on HIV replication.

  • Functional association of cyclophilin A with HIV-1 virions. Thali, Markus; Bukivsky, Anatoly // Nature;11/24/1994, Vol. 372 Issue 6504, p363 

    Reports on the functional effect the formation of viral particles by p55 that contain cyclophilin A to HIV-1 virions. Effect of cyclospirin to cyclophilin A in vitro binding; Comparison of HIV-1 to other immunodeficiency viruses.

  • An African HIV-1 sequence from 1959 and implications for the origin of the epidemic. Zhu, Tuofu; Korber, Bette T.; Nahmias, Andre J.; Hooper, Edward; Sharp, Paul M.; Ho, David D. // Nature;2/5/1998, Vol. 391 Issue 6667, p594 

    Reports the amplification and characterization of viral sequences from a 1959 African plasma sample that was previously found to be HIV-1 seropositive, thought to be the oldest known case of HIV-1 infection. What genetic analysis showed; Methods; The suggestion, if available, that HIV-1...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics